Results 141 to 150 of about 384,620 (341)

Cost‐effectiveness of low dose colchicine prophylaxis when starting allopurinol using the “start‐low go‐slow” approach for gout: evidence from a non‐inferiority randomised double‐blind placebo‐controlled trial.

open access: yesArthritis Care &Research, Accepted Article.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko   +4 more
wiley   +1 more source

Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19

open access: yesJournal of Inflammation Research, 2021
Chen Xu,1,* Junli Fan,1,* Yi Luo,1,* Ziwu Zhao,1,* Peng Tang,1,* Gui Yang,1 Yunbao Pan,1 Shuang Guo,1 Yingjuan Liu,1 Yong Xiong,2 Wen Xie,1 Xinghua Long1 1Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan,
Xu C   +11 more
doaj  

Adipokines and Associations with Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis

open access: yesArthritis Care &Research, Accepted Article.
Purpose We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker   +9 more
wiley   +1 more source

RHEUMATOID FACTOR IN SERUM OF INDIVIDUALS EXPOSED TO ASBESTOS* [PDF]

open access: bronze, 1965
B Pernis   +2 more
openalex   +1 more source

Targeted delivery of anti-inflammatory therapy to rheumatoid tissue by fusion proteins containing an IL-4-linked synovial targeting peptide [PDF]

open access: yes, 2011
We provide first-time evidence that the synovial endothelium-targeting peptide (SyETP) CKSTHDRLC successfully delivers conjugated IL-4 to human rheumatoid synovium transplanted into SCID mice. SyETP, previously isolated by in vivo phage display and shown
Ahuva Nissim   +10 more
core   +1 more source

Identifying High‐Impact Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus‐Based Approach

open access: yesArthritis Care &Research, Accepted Article.
Objective We conducted formative research aimed at identifying solutions that address inequitable health outcomes in lupus due to adverse social determinants of health. Methods We conducted a search for keywords which provided insights into potential solutions and initiatives underway. An advisory panel of lupus experts iteratively reviewed the list of
Joy Buie   +11 more
wiley   +1 more source

Musculoskeletal Sarcoidosis and Rheumatoid Factor [PDF]

open access: yes, 1972
Articular manifestations of sarcoidosis were present in 19 of our 60 patients (32%). This correlates with previously reported studies. In all of our cases but one, the articular manifestations subsided in eight weeks.
Owen, Duncan S., Jr.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy